BamSEC and AlphaSense Join Forces
Learn More

Sana Biotechnology Inc.

NASDAQ: SANA    
Share price (12/20/24): $1.65    
Market cap (12/20/24): $368 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3
from S-1 70 pages Stock Purchase Agreement by and Among Sana Biotechnology, Inc., Oscine Holdings, LLC, and Each of the Members of Oscine Holdings, LLC, Dated as of September 10, 2020
12/34/56
EX-2.2
from S-1 77 pages Stock Purchase Agreement by and Among Sana Biotechnology, Inc., Cytocardia, Inc., Each of the Stockholders of Cytocardia, Inc., and Scott Thies, as Sellers’ Representative, Dated as of November 12, 2019
12/34/56
EX-2.1(C)
from S-1 3 pages Second Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1(B)
from S-1 3 pages Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1(A)
from S-1 123 pages Agreement and Plan of Merger by and Among SANA Biotechnology, Inc., Sana Biotechnology IV, Inc., Cobalt Biomedicine, Inc. and Venturelabs VI, Inc., Solely in Its Capacity as the Stockholders’ Representative Dated as of December 20, 2018
12/34/56
EX-2.3
from DRS/A 70 pages Stock Purchase Agreement by and Among Sana Biotechnology, Inc., Oscine Holdings, LLC, and Each of the Members of Oscine Holdings, LLC, Dated as of September 10, 2020
12/34/56
EX-2.2
from DRS/A 77 pages Stock Purchase Agreement by and Among Sana Biotechnology, Inc., Cytocardia, Inc., Each of the Stockholders of Cytocardia, Inc., and Scott Thies, as Sellers’ Representative, Dated as of November 12, 2019
12/34/56
EX-2.1(C)
from DRS/A 3 pages Second Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1(B)
from DRS/A 3 pages Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1(A)
from DRS/A 123 pages Agreement and Plan of Merger by and Among SANA Biotechnology, Inc., Sana Biotechnology IV, Inc., Cobalt Biomedicine, Inc. and Venturelabs VI, Inc., Solely in Its Capacity as the Stockholders’ Representative Dated as of December 20, 2018
12/34/56